scispace - formally typeset
H

Husam Malibary

Researcher at King Abdulaziz University

Publications -  10
Citations -  95

Husam Malibary is an academic researcher from King Abdulaziz University. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 3, co-authored 5 publications receiving 29 citations.

Papers
More filters
Journal ArticleDOI

Quality of Life (QoL) among medical students in Saudi Arabia: a study using the WHOQOL-BREF instrument

TL;DR: Although gender and academic year had no impact on the students’ QoL, better-performing students reported lower psychological health and social relationships scores, and the WHOQOL-BREF is valid and reliable for assessingQoL among Saudi medical students.
Journal ArticleDOI

Nigella sativa for the treatment of COVID-19: An open-label randomized controlled clinical trial.

TL;DR: In this article, the authors evaluated the efficacy of Nigella sativa oil (NSO) treatment in patients with mild Coronavirus Disease-2019 (COVID-19) and found that NSO supplementation was associated with faster recovery of symptoms than usual care alone.
Journal ArticleDOI

Nigella sativa supplementation to treat symptomatic mild COVID-19: A structured summary of a protocol for a randomised, controlled, clinical trial.

TL;DR: To investigate the potential efficacy of Nigella sativa (NS) oil supplementation on the outcomes of patients with mild Coronavirus Disease 2019 (COVID-19), a Prospective, two-arm, parallel-group, randomised (1:1 allocation ratio), open-label, controlled, exploratory phase II clinical trial of oral NS oil in Patients with mild COVID- 19.
Journal ArticleDOI

Description and Analysis of Cytokine Storm in Registered COVID-19 Clinical Trials: A Systematic Review.

TL;DR: In this paper, the authors describe the characteristics of clinical trials that focused on COVID-19 patients with cytokine release syndrome (CRS) and the variability in CRS definitions.
Journal ArticleDOI

Bibliometric Analysis and Visualization Mapping of Anthrax Vaccine Publications from 1991 through 2021

TL;DR: The United States of America (USA) was the most dominant country in terms of publications, citations, corresponding author country, and global collaboration in anthrax vaccine research.